Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Surmodics, Inc. - Common Stock
(NQ:
SRDX
)
42.98
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Surmodics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
April 03, 2025
From
Surmodics, Inc.
Via
Business Wire
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private
↗
March 07, 2025
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's 2017 again.
Via
Benzinga
Why Surmodics Stock Is Falling On Friday
↗
March 07, 2025
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
Via
Benzinga
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR
March 06, 2025
From
Surmodics, Inc.
Via
Business Wire
Top 3 Health Care Stocks You'll Regret Missing This Month
↗
February 06, 2025
Via
Benzinga
Surmodics Earnings Analysis: Q1 Recap
↗
January 30, 2025
Via
Benzinga
Assessing Surmodics: Insights From 5 Financial Analysts
↗
May 30, 2024
Via
Benzinga
Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries
February 03, 2025
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results
January 30, 2025
From
Surmodics, Inc.
Via
Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results
November 06, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System
October 30, 2024
From
Surmodics, Inc.
Via
Business Wire
Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter
October 01, 2024
From
Surmodics, Inc.
Via
Business Wire
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024
↗
July 31, 2024
SRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via
InvestorPlace
Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results
July 31, 2024
From
Surmodics, Inc.
Via
Business Wire
SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX
July 17, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATRI, SRDX, AGS, VAPO on Behalf of Shareholders
July 08, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, SRDX, ATRI on Behalf of Shareholders
July 04, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
June 10, 2024
From
Surmodics, Inc.
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
June 06, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
May 30, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 29, 2024
Via
Benzinga
Surmodics Stock Rockets, But Merck Stock Little Moved, On Takeover Deals
↗
May 29, 2024
Surmodics stock hit a two-year high on its GPCR takeover, but Merck stock was little moved on its EyeBio deal.
Via
Investor's Business Daily
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
↗
May 29, 2024
Surmodics will be acquired by GTCR for $43.00 per share, totaling $627 million. This 41.1% premium reflects Surmodics' advancements in surface modification for medical devices and IVD technologies.
Via
Benzinga
Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
↗
May 29, 2024
Via
Benzinga
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
May 29, 2024
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 29, 2024
Via
Benzinga
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
May 29, 2024
From
Surmodics, Inc.
Via
Business Wire
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
May 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 01, 2024
Via
Benzinga
SRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q2 2024
↗
May 01, 2024
SRDX stock results show that Surmodics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
